We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$14.2B
1-Year Est. Return
24.58%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+24.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$589M
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Industrials | 12.27% |
| 4 | Healthcare | 11.72% |
| 5 | Consumer Discretionary | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Pagaya Technologies
PGY
$1.41B
| $32.1K | ﹤0.01% |
2,756
-19,376
| -88% | -$306K |
|
852
ThredUp
TDUP
$791M
| $31.7K | ﹤0.01% |
+9,670
| New | +$44.8K |
|
|
MPT
853
Medical Properties Trust
MPT
$2.89B
| $30.2K | ﹤0.01% |
+6,519
| New | +$34K |
|
854
Groupon
GRPN
$1.03B
| $29.3K | ﹤0.01% |
2,458
-15,360
| -86% | -$205K |
|
855
Kadant
KAI
$3.61B
| $28.1K | ﹤0.01% |
96
-2,471
| -96% | -$794K |
|
|
INVX
856
Innovex International
INVX
$1.91B
| $28K | ﹤0.01% |
+1,147
| New | +$28.8K |
|
857
Sphere Entertainment
SPHR
$5.02B
| $26.6K | ﹤0.01% |
+227
| New | +$23.8K |
|
858
Archrock
AROC
$6.71B
| $25.5K | ﹤0.01% |
+732
| New | +$23.4K |
|
|
PENG
859
Penguin Solutions Inc
PENG
$3.07B
| $25.1K | ﹤0.01% |
1,428
-25,808
| -95% | -$491K |
|
|
ARI
860
Apollo Commercial Real Estate
ARI
$893M
| $25K | ﹤0.01% |
+2,371
| New | +$24.7K |
|
861
SunCoke Energy
SXC
$730M
| $24.2K | ﹤0.01% |
+3,717
| New | +$26.3K |
|
862
Hillman Solutions
HLMN
$1.56B
| $23.3K | ﹤0.01% |
+2,802
| New | +$25.3K |
|
863
West Pharmaceutical
WST
$25.3B
| $23.1K | ﹤0.01% |
92
-2,434
| -96% | -$606K |
|
864
Fox Class A
FOXA
$23.9B
| $21.4K | ﹤0.01% |
+366
| New | +$23.4K |
|
865
Bristow Group
VTOL
$1.34B
| $21.1K | ﹤0.01% |
+449
| New | +$19.7K |
|
866
Jones Lang LaSalle
JLL
$15B
| $18.3K | ﹤0.01% |
+60
| New | +$19.4K |
|
867
Kyndryl
KD
$2.62B
| $16.5K | ﹤0.01% |
+1,261
| New | +$22.2K |
|
|
CWEN.A
868
DELISTED
Clearway Energy Class A
CWEN.A
| $15K | ﹤0.01% |
+382
| New | +$13.6K |
|
869
Aramark
ARMK
$14.8B
| $13.5K | ﹤0.01% |
+333
| New | +$13.2K |
|
870
Benchmark Electronics
BHE
$3.02B
| $13.2K | ﹤0.01% |
+236
| New | +$12.7K |
|
871
Concentrix
CNXC
$1.47B
| $11K | ﹤0.01% |
402
-31,714
| -99% | -$1.13M |
|
872
Hovnanian Enterprises
HOV
$766M
| $10.6K | ﹤0.01% |
+96
| New | +$11.2K |
|
873
Hawaiian Electric Industries
HE
$2.34B
| $8.71K | ﹤0.01% |
+587
| New | +$8.88K |
|
874
Freshworks
FRSH
$2.76B
| $7.35K | ﹤0.01% |
+915
| New | +$8.44K |
|
875
NMI Holdings
NMIH
$3.16B
| $3.9K | ﹤0.01% |
+104
| New | +$4.03K |
|
Similar funds
BIP
BPC
ETC
SSA
X
CM
BBVA
IFP
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners deployed $589M of net new capital in Q1 2026, opening 515 new positions and adding to 214 existing holdings. Its largest new stake was Citigroup: 1,180,436 shares worth $134M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $303M trimmed.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.